Arab Drug Company sees 24% YoY profit increase in FY2023/24

Updated 9/1/2024 10:53:00 AM
Arab Drug Company sees 24% YoY profit increase in FY2023/24

Arab Finance: Arab Drug Company’s (ADCI) net profits after tax jumped 24.2% year on year (YoY) in the fiscal year (FY) 2023/2024, according to the company’s audited financial statement.

Net profits after tax recorded EGP 102.824 million last FY, up from EGP 82.77 million a year earlier.

Meanwhile, total revenues rose to EGP 785.522 million from EGP 633.733 million.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.

Related News